CommercialCoverageMedium impact
07.03.09x, Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies
Independence Blue Cross·Neurology, PM&R (Physical Medicine & Rehab), Orthopedics +1 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has updated their medical policy for electromyography (EMG) studies, nerve conduction studies (NCS), and related electrodiagnostic procedures, effective October 1, 2025. This commercial policy update may affect coverage criteria, billing requirements, or documentation standards for these neurological diagnostic tests.
Action Required
Before October 1, 2025: Billing team and providers should review the updated Independence Blue Cross policy 07.03.09x for EMG/NCS studies at the source URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards. Update billing procedures and provider workflows accordingly to ensure continued claim approval for electrodiagnostic studies.